Literature DB >> 12200447

Binding of C/EBP and RBP (CBF1) to overlapping sites regulates interleukin-6 gene expression.

Lynne D Vales1, Erika M Friedl.   

Abstract

The ILRE (interleukin response element) contained within the promoter of the interleukin-6 (IL-6) gene is defined as the site recognized by the p65 NF-kappaB transcriptional activator and is crucial for activation of the IL-6 gene. The region of the promoter containing the ILRE is complex containing a CCAAT enhancer-binding protein (C/EBP) site immediately upstream of the ILRE, which is required for optimal activation of the IL-6 gene. Additionally, the ILRE overlaps a site that is recognized by the mammalian transcriptional repressor RBP (CBF-1), and RBP binding within the ILRE region represses activated IL-6 expression. In this study, the complexity of this region is further revealed by the identification of a second nested C/EBP site, which overlaps that of RBP and therefore also the ILRE. Optimal activation requires both the upstream and newly identified C/EBP sites in conjunction with the p65 NF-kappaB binding site. We previously reported that RBP represses IL-6 activation but does not target p65. We extend these analyses here to show that RBP binding does not occlude p65 from binding but instead directly overlaps the newly identified downstream C/EBP site, thereby impeding p65-C/EBP-mediated co-activation. This result suggests a role for RBP in the repression of other genes containing a C/EBP site that exhibits sequence overlap with the RBP site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200447     DOI: 10.1074/jbc.M207363200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Innate immune responses in NF-kappaB-repressing factor-deficient mice.

Authors:  Natali Froese; Michael Schwarzer; Ina Niedick; Ursula Frischmann; Mario Köster; Andrea Kröger; Peter P Mueller; Mahtab Nourbakhsh; Bastian Pasche; Jörg Reimann; Peter Staeheli; Hansjörg Hauser
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

2.  The effect of cyclosporin A on airway cell proinflammatory signaling and pneumonia.

Authors:  Valerie Waters; Sach Sokol; Bharat Reddy; Grace Soong; Jarin Chun; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2005-05-05       Impact factor: 6.914

3.  Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.

Authors:  Seiji Maruo; Eric Johannsen; Diego Illanes; Andrew Cooper; Elliott Kieff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter.

Authors:  Prem Prakash Singh; Bhavya Voleti; Alok Agrawal
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

5.  RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway.

Authors:  Guangtao Zhang; Shingo Tanaka; Shabierjiang Jiapaer; Hemragul Sabit; Sho Tamai; Masashi Kinoshita; Mitsutoshi Nakada
Journal:  Cancer Sci       Date:  2020-09-22       Impact factor: 6.716

6.  MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines.

Authors:  Mario Dandrea; Massimo Donadelli; Chiara Costanzo; Aldo Scarpa; Marta Palmieri
Journal:  Nucleic Acids Res       Date:  2009-09-10       Impact factor: 16.971

Review 7.  Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?

Authors:  Mamneet Manghera; Renée N Douville
Journal:  Retrovirology       Date:  2013-02-09       Impact factor: 4.602

8.  Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation.

Authors:  Kristian-Christos Ngamsri; Christoph Jans; Rizki A Putri; Katharina Schindler; Jutta Gamper-Tsigaras; Claudia Eggstein; David Köhler; Franziska M Konrad
Journal:  Front Immunol       Date:  2020-03-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.